My Quote Request
No products added yet
6505-01-126-3164
20 Products
NDC00003-0251-50
ESTRADIOL VALERATE INJECTION,USP
NSN, MFG P/N
6505011263164
NSN
6505-01-126-3164
NDC00003-0251-50
ESTRADIOL VALERATE INJECTION,USP
NSN, MFG P/N
6505011263164
NSN
6505-01-126-3164
MFG
KING PHARMACEUTICALS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 40.000 MILLIGRAMS ESTRADIOL VALERATE PER MILLILITER
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ESTRADIOL VALERATE INJECTION USP 4MG/ML 5ML VIAL
PRIMARY CONTAINER CONTENT QUANTITY: 5.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
Related Searches:
LIMBITROL 10-25
CHLORDIAZEPOXIDE AND AMITRIPTYLINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505011261853
NSN
6505-01-126-1853
LIMBITROL 10-25
CHLORDIAZEPOXIDE AND AMITRIPTYLINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505011261853
NSN
6505-01-126-1853
MFG
HOFFMANN-LA ROCHE INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 25.000 MILLIGRAMS AMITRIPTYLINE HYDROCHLORIDE ACTIVE INGREDIENT AND 10.000 MILLIGRAMS CHLORDIAZEPOXIDE ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: 100 INDIVIDUALLY SEALED TABLETS
Related Searches:
NDC00140-0071-49
CHLORDIAZEPOXIDE AND AMITRIPTYLINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505011261853
NSN
6505-01-126-1853
NDC00140-0071-49
CHLORDIAZEPOXIDE AND AMITRIPTYLINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505011261853
NSN
6505-01-126-1853
MFG
HOFFMANN-LA ROCHE INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 25.000 MILLIGRAMS AMITRIPTYLINE HYDROCHLORIDE ACTIVE INGREDIENT AND 10.000 MILLIGRAMS CHLORDIAZEPOXIDE ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: 100 INDIVIDUALLY SEALED TABLETS
Related Searches:
LIBRAX
CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE CAPSULES
NSN, MFG P/N
6505011261927
NSN
6505-01-126-1927
LIBRAX
CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE CAPSULES
NSN, MFG P/N
6505011261927
NSN
6505-01-126-1927
MFG
HOFFMANN-LA ROCHE INC.
Description
(NON-CORE DATA) UNIT PACKAGE TYPE: PACKAGE
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS CHLORDIAZEPOXIDE HYDROCHLORIDE ACTIVE INGREDIENT AND 2.500 MILLIGRAMS CLIDINIUM BROMIDE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 10.000
CAPSULE TYPE: ANY ACCEPTABLE
FEATURES PROVIDED: INDIVIDUALLY SEALED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LIBRAX CAPSULES 10 STRIPS OF 10 CAPSULES
PRIMARY CONTAINER TYPE: STRIP
SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,HOFFMANN-LA ROCHE INC
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
LIBRAX CAPSULES
CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE CAPSULES
NSN, MFG P/N
6505011261927
NSN
6505-01-126-1927
LIBRAX CAPSULES
CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE CAPSULES
NSN, MFG P/N
6505011261927
NSN
6505-01-126-1927
MFG
HOFFMANN-LA ROCHE INC.
Description
(NON-CORE DATA) UNIT PACKAGE TYPE: PACKAGE
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS CHLORDIAZEPOXIDE HYDROCHLORIDE ACTIVE INGREDIENT AND 2.500 MILLIGRAMS CLIDINIUM BROMIDE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 10.000
CAPSULE TYPE: ANY ACCEPTABLE
FEATURES PROVIDED: INDIVIDUALLY SEALED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LIBRAX CAPSULES 10 STRIPS OF 10 CAPSULES
PRIMARY CONTAINER TYPE: STRIP
SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,HOFFMANN-LA ROCHE INC
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
NDC00140-0007-49
CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE CAPSULES
NSN, MFG P/N
6505011261927
NSN
6505-01-126-1927
NDC00140-0007-49
CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE CAPSULES
NSN, MFG P/N
6505011261927
NSN
6505-01-126-1927
MFG
HOFFMANN-LA ROCHE INC.
Description
(NON-CORE DATA) UNIT PACKAGE TYPE: PACKAGE
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS CHLORDIAZEPOXIDE HYDROCHLORIDE ACTIVE INGREDIENT AND 2.500 MILLIGRAMS CLIDINIUM BROMIDE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 10.000
CAPSULE TYPE: ANY ACCEPTABLE
FEATURES PROVIDED: INDIVIDUALLY SEALED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LIBRAX CAPSULES 10 STRIPS OF 10 CAPSULES
PRIMARY CONTAINER TYPE: STRIP
SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,HOFFMANN-LA ROCHE INC
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
NDC00187-4100-10
CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE CAPSULES
NSN, MFG P/N
6505011261927
NSN
6505-01-126-1927
NDC00187-4100-10
CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE CAPSULES
NSN, MFG P/N
6505011261927
NSN
6505-01-126-1927
MFG
VALEANT PHARMACEUTICALS INTERNATIONAL
Description
(NON-CORE DATA) UNIT PACKAGE TYPE: PACKAGE
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS CHLORDIAZEPOXIDE HYDROCHLORIDE ACTIVE INGREDIENT AND 2.500 MILLIGRAMS CLIDINIUM BROMIDE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 10.000
CAPSULE TYPE: ANY ACCEPTABLE
FEATURES PROVIDED: INDIVIDUALLY SEALED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LIBRAX CAPSULES 10 STRIPS OF 10 CAPSULES
PRIMARY CONTAINER TYPE: STRIP
SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,HOFFMANN-LA ROCHE INC
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
NDC00591-4007-01
CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE CAPSULES
NSN, MFG P/N
6505011261927
NSN
6505-01-126-1927
NDC00591-4007-01
CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE CAPSULES
NSN, MFG P/N
6505011261927
NSN
6505-01-126-1927
MFG
DANBURY PHARMACAL INC
Description
(NON-CORE DATA) UNIT PACKAGE TYPE: PACKAGE
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS CHLORDIAZEPOXIDE HYDROCHLORIDE ACTIVE INGREDIENT AND 2.500 MILLIGRAMS CLIDINIUM BROMIDE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 10.000
CAPSULE TYPE: ANY ACCEPTABLE
FEATURES PROVIDED: INDIVIDUALLY SEALED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LIBRAX CAPSULES 10 STRIPS OF 10 CAPSULES
PRIMARY CONTAINER TYPE: STRIP
SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,HOFFMANN-LA ROCHE INC
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
NDC00603-2714-21
CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE CAPSULES
NSN, MFG P/N
6505011261927
NSN
6505-01-126-1927
NDC00603-2714-21
CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE CAPSULES
NSN, MFG P/N
6505011261927
NSN
6505-01-126-1927
MFG
GENERICS BIDCO I LLC DBA QUALITEST PHARMACEUTICALS
Description
(NON-CORE DATA) UNIT PACKAGE TYPE: PACKAGE
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS CHLORDIAZEPOXIDE HYDROCHLORIDE ACTIVE INGREDIENT AND 2.500 MILLIGRAMS CLIDINIUM BROMIDE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 10.000
CAPSULE TYPE: ANY ACCEPTABLE
FEATURES PROVIDED: INDIVIDUALLY SEALED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LIBRAX CAPSULES 10 STRIPS OF 10 CAPSULES
PRIMARY CONTAINER TYPE: STRIP
SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,HOFFMANN-LA ROCHE INC
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
NDC00677-1247-01
CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE CAPSULES
NSN, MFG P/N
6505011261927
NSN
6505-01-126-1927
NDC00677-1247-01
CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE CAPSULES
NSN, MFG P/N
6505011261927
NSN
6505-01-126-1927
MFG
BAXTER HEALTHCARE CORP BAXTER AIRLIFE/PHARMASEAL DIV
Description
(NON-CORE DATA) UNIT PACKAGE TYPE: PACKAGE
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS CHLORDIAZEPOXIDE HYDROCHLORIDE ACTIVE INGREDIENT AND 2.500 MILLIGRAMS CLIDINIUM BROMIDE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 10.000
CAPSULE TYPE: ANY ACCEPTABLE
FEATURES PROVIDED: INDIVIDUALLY SEALED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LIBRAX CAPSULES 10 STRIPS OF 10 CAPSULES
PRIMARY CONTAINER TYPE: STRIP
SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,HOFFMANN-LA ROCHE INC
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
NDC00904-2503-60
CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE CAPSULES
NSN, MFG P/N
6505011261927
NSN
6505-01-126-1927
NDC00904-2503-60
CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE CAPSULES
NSN, MFG P/N
6505011261927
NSN
6505-01-126-1927
MFG
MAJOR PHARMACEUTICALS INC
Description
(NON-CORE DATA) UNIT PACKAGE TYPE: PACKAGE
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS CHLORDIAZEPOXIDE HYDROCHLORIDE ACTIVE INGREDIENT AND 2.500 MILLIGRAMS CLIDINIUM BROMIDE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 10.000
CAPSULE TYPE: ANY ACCEPTABLE
FEATURES PROVIDED: INDIVIDUALLY SEALED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LIBRAX CAPSULES 10 STRIPS OF 10 CAPSULES
PRIMARY CONTAINER TYPE: STRIP
SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,HOFFMANN-LA ROCHE INC
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
NDC52152-0018-02
CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE CAPSULES
NSN, MFG P/N
6505011261927
NSN
6505-01-126-1927
NDC52152-0018-02
CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE CAPSULES
NSN, MFG P/N
6505011261927
NSN
6505-01-126-1927
MFG
AMIDE PHARMACEUTICAL INC
Description
(NON-CORE DATA) UNIT PACKAGE TYPE: PACKAGE
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS CHLORDIAZEPOXIDE HYDROCHLORIDE ACTIVE INGREDIENT AND 2.500 MILLIGRAMS CLIDINIUM BROMIDE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 10.000
CAPSULE TYPE: ANY ACCEPTABLE
FEATURES PROVIDED: INDIVIDUALLY SEALED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LIBRAX CAPSULES 10 STRIPS OF 10 CAPSULES
PRIMARY CONTAINER TYPE: STRIP
SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,HOFFMANN-LA ROCHE INC
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
NDC00147-0137-10
MECLIZINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505011263159
NSN
6505-01-126-3159
NDC00147-0137-10
MECLIZINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505011263159
NSN
6505-01-126-3159
MFG
PROCTER & GAMBLE PHARMACEUTICALS INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 12.500 MILLIGRAMS MECLIZINE HYDROCHLORIDE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,AMERICAN CYANAMID CO,LEDERLE LABS DIV
Related Searches:
NDC00662-2100-66
MECLIZINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505011263159
NSN
6505-01-126-3159
NDC00662-2100-66
MECLIZINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505011263159
NSN
6505-01-126-3159
MFG
ROERIG DIV PFIZER INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 12.500 MILLIGRAMS MECLIZINE HYDROCHLORIDE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,AMERICAN CYANAMID CO,LEDERLE LABS DIV
Related Searches:
AKINETON
BIPERIDEN HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505011263161
NSN
6505-01-126-3161
AKINETON
BIPERIDEN HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505011263161
NSN
6505-01-126-3161
MFG
KNOLL PHARMACEUTICALS A UNIT OF BASF K AND F CORP
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.000 MILLIGRAMS BIPERIDEN HYDROCHLORIDE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
AKINETON TABLETS
BIPERIDEN HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505011263161
NSN
6505-01-126-3161
AKINETON TABLETS
BIPERIDEN HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505011263161
NSN
6505-01-126-3161
MFG
KNOLL PHARMACEUTICALS A UNIT OF BASF K AND F CORP
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.000 MILLIGRAMS BIPERIDEN HYDROCHLORIDE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00044-0120-04
BIPERIDEN HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505011263161
NSN
6505-01-126-3161
NDC00044-0120-04
BIPERIDEN HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505011263161
NSN
6505-01-126-3161
MFG
KNOLL PHARMACEUTICALS A UNIT OF BASF K AND F CORP
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.000 MILLIGRAMS BIPERIDEN HYDROCHLORIDE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
01-4853
HYDROXYZINE PAMOATE CAPSULES,USP
NSN, MFG P/N
6505011263163
NSN
6505-01-126-3163
01-4853
HYDROXYZINE PAMOATE CAPSULES,USP
NSN, MFG P/N
6505011263163
NSN
6505-01-126-3163
MFG
GOLDLINE LABORATORIES INC. DBA GOLDLINE LABORATORIES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS HYDROXYZINE PAMOATE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 1000.000
CAPSULE TYPE: ANY ACCEPTABLE
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00182-1099-10
HYDROXYZINE PAMOATE CAPSULES,USP
NSN, MFG P/N
6505011263163
NSN
6505-01-126-3163
NDC00182-1099-10
HYDROXYZINE PAMOATE CAPSULES,USP
NSN, MFG P/N
6505011263163
NSN
6505-01-126-3163
MFG
GOLDLINE LABORATORIES INC. DBA GOLDLINE LABORATORIES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS HYDROXYZINE PAMOATE ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 1000.000
CAPSULE TYPE: ANY ACCEPTABLE
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
DELESTROGEN
ESTRADIOL VALERATE INJECTION,USP
NSN, MFG P/N
6505011263164
NSN
6505-01-126-3164
DELESTROGEN
ESTRADIOL VALERATE INJECTION,USP
NSN, MFG P/N
6505011263164
NSN
6505-01-126-3164
MFG
SQUIBB E R AND SONS INC WORLD HQ
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 40.000 MILLIGRAMS ESTRADIOL VALERATE PER MILLILITER
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ESTRADIOL VALERATE INJECTION USP 4MG/ML 5ML VIAL
PRIMARY CONTAINER CONTENT QUANTITY: 5.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
